Inventor
MARTIN DONOVAN
Inventor
US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes53%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations40%
A61MDevices for introducing media into, or onto, the body7%
PatentTitleYear
12,514,837Stable levothyroxine compositions in aprotic polar solvents202612,263,174Methods and compositions for treatment of pulmonary hypertension and other lung disorders202511,957,736Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the same202411,590,205Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents202311,576,951Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the same202311,491,161Methods and compositions for treatment of pulmonary hypertension and other lung disorders202211,491,160Methods and compositions for treatment of pulmonary hypertension and other lung disorders202211,471,623Powder dispersion methods and devices2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to RESPIRA THERAPEUTICS INC (4)· patent assignee history
2022–2026Based in US· patent location history
2023–2026Patents assigned to XERIS PHARMACEUTICALS INC (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| RESPIRA THERAPEUTICS INC | 4 | 2022–2025 |
| XERIS PHARMACEUTICALS INC | 4 | 2023–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 8 | 2022–2026 |